TomoTherapy Sets IPO at 10.9 Million Shares, $15-$17
WASHINGTON, April 16 (Reuters) - TomoTherapy Inc., which develops and sells radiation treatments for cancer, on Monday set its planned initial public offering at 10.9 million shares for an estimated $15 to $17 each.